Chiorean, E. G., Von Hoff, D. D., Tabernero, J., El-Maraghi, R., Ma, W. W., Reni, M., . . . Goldstein, D. (2016). Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer. Br J Cancer.
Chicago Style CitationChiorean, E Gabriela, et al. "Second-line Therapy After Nab-paclitaxel Plus Gemcitabine or After Gemcitabine for Patients With Metastatic Pancreatic Cancer." Br J Cancer 2016.
Cita MLAChiorean, E Gabriela, et al. "Second-line Therapy After Nab-paclitaxel Plus Gemcitabine or After Gemcitabine for Patients With Metastatic Pancreatic Cancer." Br J Cancer 2016.
Atenció: Aquestes cites poden no estar 100% correctes.